ArticleFrontiers in oncology2022

Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx.

Dongshen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.